Morten Mau-Sørensen

12PUBLICATIONS
71CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 23, 2026
Circulating tumor DNA-guided response evaluation in patients with previously treated gastroesophageal adenocarcinoma.

|May 08, 2025
Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patients.

Morten Ladekarl, Mette Louise Mørk, Emma Skotte Albertsen

|Oct 05, 2024
Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer.

Cecilie Riis Iden, Salah Mohammad Mustafa, Nadia Øgaard

|Aug 05, 2024
Human Epidermal Growth Factor Receptor 2 Pan Tumor Indication for Trastuzumab Deruxtecan.

Jan Trøst Jørgensen, Kristian Egebjerg, Anne-Vibeke Lænkholm

|Apr 17, 2024
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors.

Neeltje Steeghs, Carlos Gomez-Roca, Kristoffer S Rohrberg

|Sep 22, 2022
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours.

Xinhui Chen, Nicolas Isambert, Rafael López-López

Pageof 2

Frequent Collaborators

2 joint publications

Debbie Robbrecht

1 joint publications

Tormod Kyrre Guren

1 joint publications

Florent Mouliere

1 joint publications

Dineika Chandrananda